-
91.Antibacterial methods and compositions utilizing n' - (4 - pyrimidinyl)-sulfanilamides 失效
标题翻译: 使用N' - (4-吡啶基) - 磺酰胺的抗菌方法和组合物公开(公告)号:US3499080A
公开(公告)日:1970-03-03
申请号:US3499080D
申请日:1969-01-22
申请人: GEIGY CHEM CORP
发明人: ZIMMERMANN MARKUS
IPC分类号: C07D239/30 , C07D239/34 , C07D239/36 , C07D239/38 , C07D239/42 , C07D239/52 , C07D239/54 , C07D239/56 , C07D239/60 , C07D239/69 , A61K27/00
CPC分类号: C07D239/30 , C07D239/34 , C07D239/36 , C07D239/38 , C07D239/42 , C07D239/52 , C07D239/54 , C07D239/56 , C07D239/60 , C07D239/69 , Y10S514/96
-
公开(公告)号:US3498984A
公开(公告)日:1970-03-03
申请号:US3498984D
申请日:1966-10-28
申请人: AMERICAN HOME PROD
发明人: SANTILLI ARTHUR A , KIM DONG H
IPC分类号: C07D239/30 , C07D239/42 , C07D239/46 , C07D239/54 , C07D51/42 , C07D51/44
CPC分类号: C07D239/30 , C07D239/42 , C07D239/47 , C07D239/54
-
公开(公告)号:US3422098A
公开(公告)日:1969-01-14
申请号:US3422098D
申请日:1964-03-10
申请人: CIBA GEIGY CORP
发明人: SCHMIDT PAUL , SCHWEIZER ERNST , EICHENBERGER KURT , WILHELM MAX
IPC分类号: A61K31/505 , C07D239/30 , C07D239/34 , C07D239/36 , C07D239/42 , C07D239/46 , C07D239/52 , C07D239/54 , C07D239/553 , C07D239/60 , C07D239/69 , A61K25/00 , C07D51/44
CPC分类号: C07D239/30 , A61K31/505 , C07D239/34 , C07D239/36 , C07D239/42 , C07D239/47 , C07D239/52 , C07D239/54 , C07D239/553 , C07D239/60 , C07D239/69
-
公开(公告)号:US3314955A
公开(公告)日:1967-04-18
申请号:US34396664
申请日:1964-02-11
申请人: OLIN MATHIESON
发明人: BOUDAKIAN MAX M , KAUFMAN CHARLES W
IPC分类号: C07D239/30
CPC分类号: C07D239/30
-
公开(公告)号:US3213090A
公开(公告)日:1965-10-19
申请号:US37565564
申请日:1964-06-16
发明人: JOSEF ROCH
IPC分类号: C07D239/30 , C07D239/42 , C07D239/46 , C07D239/47 , C07D239/48 , C07D239/50 , C07D401/04 , C07D401/14 , C07D487/04
CPC分类号: C07D239/30 , C07D239/42 , C07D239/47 , C07D239/48 , C07D239/50 , C07D401/04 , C07D401/14 , C07D487/04
-
公开(公告)号:US3017412A
公开(公告)日:1962-01-16
申请号:US83516059
申请日:1959-08-04
申请人: GEIGY AG J R
IPC分类号: C07D239/30 , C07D241/26 , C07D241/28 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12 , C07D475/02 , C07D487/14 , C08K5/3492 , C08L67/02 , C11D3/28 , C11D3/42 , D06L3/12 , H01M4/86 , H01M8/14
CPC分类号: C07D239/30 , C07D241/26 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12 , C07D475/02 , C07D487/14 , C08K5/34926 , C08L67/02 , C11D3/28 , C11D3/42 , D06L4/614 , H01M4/86 , H01M8/14 , Y02P70/56
-
公开(公告)号:US2879150A
公开(公告)日:1959-03-24
申请号:US55368355
申请日:1955-12-19
申请人: MONSANTO CHEMICALS
发明人: DEEBEL GEORGE F , HAMM PHILIP C
IPC分类号: C07D239/30
CPC分类号: C07D239/30
-
公开(公告)号:US2153016A
公开(公告)日:1939-04-04
申请号:US11741736
申请日:1936-12-23
申请人: RESEARCH CORP
发明人: WILLIAMS ROBERT R
IPC分类号: C07D239/30 , C07D239/36 , C07D239/42
CPC分类号: C07D239/30 , C07D239/36 , C07D239/42
-
公开(公告)号:US11793771B2
公开(公告)日:2023-10-24
申请号:US17838400
申请日:2022-06-13
申请人: CHEMOCENTRYX, INC.
发明人: Christopher Lange , Viengkham Malathong , Darren J. McMurtrie , Sreenivas Punna , Rajinder Singh , Ju Yang , Penglie Zhang
IPC分类号: A61K31/085 , C07D211/40 , A61P35/00 , C07C215/12 , C07F5/02 , C07D401/14 , C07D213/30 , C07D405/12 , C07C229/22 , C07D319/18 , C07D417/12 , A61K45/06 , C07C235/42 , C07C235/20 , C07D239/42 , C07C255/54 , C07D213/61 , C07D413/12 , C07D205/04 , A61P31/00 , C07D237/08 , C07D401/12 , C07D213/85 , C07D239/30 , C07D405/14 , C07D401/04 , C07D409/12 , C07D213/80 , A61P29/00 , C07C317/22 , C07F9/58 , A61K31/015 , A61K31/03 , A61K31/277 , A61K38/00 , C07C43/168 , A61K31/36 , A61K31/44 , A61K31/505 , A61K47/34
CPC分类号: A61K31/085 , A61K31/015 , A61K31/03 , A61K31/277 , A61K38/00 , A61K45/06 , A61P29/00 , A61P31/00 , A61P35/00 , C07C43/168 , C07C215/12 , C07C229/22 , C07C235/20 , C07C235/42 , C07C255/54 , C07C317/22 , C07D205/04 , C07D211/40 , C07D213/30 , C07D213/61 , C07D213/80 , C07D213/85 , C07D237/08 , C07D239/30 , C07D239/42 , C07D319/18 , C07D401/04 , C07D401/12 , C07D401/14 , C07D405/12 , C07D405/14 , C07D409/12 , C07D413/12 , C07D417/12 , C07F5/025 , C07F9/58 , A61K31/36 , A61K31/44 , A61K31/505 , A61K47/34 , C07C2601/02 , C07C2602/08 , Y02A50/30
摘要: Compounds are provided that are useful as immunomodulators. The compounds have the following Formula (II):
including stereoisomers and pharmaceutically acceptable salts thereof, wherein R1, R2a, R2b, R2c, R3, R4, R6a, R6b, m and n are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.-
公开(公告)号:US11780858B2
公开(公告)日:2023-10-10
申请号:US17530119
申请日:2021-11-18
申请人: Sprint Bioscience AB
IPC分类号: C07F5/04 , C07D213/64 , C07D213/68 , C07D213/69 , C07D239/30 , C07D239/47 , C07D241/04 , C07D401/04 , C07D401/14 , C07D413/04 , C07D413/14 , C07D417/12 , C07D417/14 , A61K45/06
CPC分类号: C07F5/04 , C07D213/64 , C07D213/68 , C07D213/69 , C07D239/30 , C07D239/47 , C07D241/04 , C07D401/04 , C07D401/14 , C07D413/04 , C07D413/14 , C07D417/12 , C07D417/14 , A61K45/06
摘要: The invention provides novel pyridinamine-pyridone and pyrimidinamine-pyridone compounds of formula (I), pharmaceutical compositions containing such compounds, and methods for using such compounds in treatment of diseases including cancer, type II diabetes, inflammatory disease, neurodegenerative disorders, cardiovascular disorders, autoimmune diseases and viral infections;
wherein R1, R2, R3 and Z are as defined in the specification.
-
-
-
-
-
-
-
-
-